Viewing Study NCT02823405


Ignite Creation Date: 2025-12-25 @ 3:28 AM
Ignite Modification Date: 2026-04-24 @ 11:00 AM
Study NCT ID: NCT02823405
Status: COMPLETED
Last Update Posted: 2020-07-07
First Post: 2016-07-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: X4P-001 and Pembrolizumab in Patients With Advanced Melanoma
Sponsor: X4 Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module